News

AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance

 Fiscal Year 2024 First Quarter Highlights Net sales of $78.7 million as reported Includes $0.7 million of Dialysis and BioSentry…

1 year ago

Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary…

1 year ago

FloraWorks Appoints Cannabis Scientist Dr. Mike McCormick as VP of Strategy

Portland, Oregon--(Newsfile Corp. - October 4, 2023) - FloraWorks Holdings Inc., a leading cannabinoid therapeutics company, announced the appointment of Dr.…

1 year ago

Awakn Life Sciences Completes MDMA Zydis(R) ODT Feasibility Study

Study Confirms MDMA Is Stable on Zydis(R) ODT and Suitable for Pre-Gastric AbsorptionToronto, Ontario--(Newsfile Corp. - October 4, 2023) -…

1 year ago

Naturevan Receives $100k P.O. and Signs Partnership Agreement with JS Foods Global

Toronto, Ontario--(Newsfile Corp. - October 4, 2023) - Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly ScreenPro Security Inc.) ("Justera" or the…

1 year ago

Lumiera Health – Date of the Annual General and Special Meeting of Shareholders and Addition to the Board of Directors

Montreal, Quebec--(Newsfile Corp. - October 4, 2023) - Lumiera Health Inc. (TSXV: NHP) (the "Company" or "Lumiera"), a company specializing…

1 year ago

Get Well Unveils Get Well 360, Its Next-Generation Consumer Digital Platform

Get Well 360 Builds on the Company's +20-Year Leadership in the Industry, Delivering Consumer-Centered Solutions That Are Proven to Activate,…

1 year ago

FSD Pharma Wins $2.8 Million Dollar Award Plus Accruing Interest from Dr. Raza Bokhari; Set Aside Motion Brought by Bokhari, Now CEO of Medicus Pharma, Dismissed by the Ontario Superior Court of Justice

TORONTO, ON / ACCESSWIRE / October 4, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

1 year ago

Halberd’s Traumatic Brain Injury (TBI) Testing Results Replicated at Mississippi State University (MSU)

JACKSON CENTER, PA / ACCESSWIRE / October 4, 2023 / Halberd Corporation's (OTC PINK:HALB) proprietary nasal spray testing results to…

1 year ago

Salix Pharmaceuticals Partners with Bellamy Young

Bellamy Young is Moving Past Stigma as She Speaks Candidly about Her Father's Struggle with Chronic Liver Disease/Cirrhosis and Resulting…

1 year ago